VISCHER AG advised AMR Action Fund. Homburger advised BioVersys AG. The AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing...
BioVersys’ Extension of its Series C Financing Round
BioVersys’ CHF 24.2 Million Series C Financing Round
MLLStart! advised Clinical Research Ventures. Walder Wyss advises BioVersys. BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for...